-- U.K. Stocks Advance as FTSE 100 Index Adds 0.3 Percent
-- B y   I n y o u n g   H w a n g
-- 2013-11-11T16:54:12Z
-- http://www.bloomberg.com/news/2013-11-11/u-k-stocks-little-changed-after-ftse-100-s-weekly-slide.html
U.K. stocks  advanced for a second
day, with the benchmark  FTSE 100 (UKX)  Index rebounding from its first
weekly loss in more than a month, as investors weighed Chinese
industrial-output data.  Lloyds Banking Group Plc rose 2.1 percent after HSBC
Holdings Plc said the lender’s margin expansion is continuing.
 Shire Plc (SHP)  added 0.9 percent after agreeing to buy ViroPharma
Inc. for about $4.2 billion. British Sky Broadcasting Group Plc
slumped the most since October 2008 after  BT Group Plc (BT/A)  won the
rights to two European soccer contests.  The FTSE 100 climbed 19.95 points, or 0.3 percent, to
6,728.37 at the close in London. The gauge fell 0.4 percent last
week as European Central Bank President  Mario Draghi  announced
an interest-rate cut, signaling a worsening regional economy.
The broader FTSE All-Share Index increased 0.3 percent today,
while Ireland’s ISEQ Index rose 0.7 percent.  “Stocks are inching up a touch as investors take heart in
 China ’s industrial output reading which showed growth
unexpectedly increased,” Ishaq Siddiqi, a London-based market
strategist at ETX Capital, wrote in a note. “At the same time
however, Fed tapering woes are capping some of the enthusiasm to
build risk exposure.”  In China,  industrial output  jumped 10.3 percent in October
from a year earlier, the National Bureau of Statistics said Nov.
9. That was higher than September growth of 10.2 percent and the
10 percent median projection in a Bloomberg News survey.  President  Xi Jinping  and top Communist Party leaders have
gathered in Beijing for a meeting known as the third plenum to
outline a blueprint to sustain growth and drive urbanization in
the world’s second-biggest economy. The meeting of about 370
officials will conclude tomorrow.  Lloyds Margins  Lloyds rose 2.1 percent to 76.77 pence. HSBC said that a
momentum in margins should continue in 2014, fueled by improving
liability spreads. Analysts’ estimates for no revenue growth
look too pessimistic, HSBC’s Peter Toeman and Robin Down wrote.  Shire climbed 0.9 percent to 2,822 pence. The purchase of
ViroPharma will give Shire access to Cinryze, a medicine for the
inflammatory condition hereditary angioedema, which complements
Shire’s own Firazyr for the same condition. The Dublin-based
drugmaker will pay $50 a share in cash, 27 percent more than
ViroPharma’s price on Nov. 8.  Schroders Plc advanced 4.3 percent to 2,542 pence. Numis
Securities Ltd. raised the  money manager  to add from hold,
saying there are potential gains in the fourth quarter from
performance fees and flows into European equities.  Lonmin Profit  Lonmin Plc (LMI)  rallied 3.9 percent to 340.9 pence. The world’s
third-largest platinum producer returned to profit after output
of the metal exceeded the company’s forecast and cost increases
were below South African inflation.  BSkyB (BSY)  slumped 11 percent to 829 pence. BT, which started
three sports channels in August, said Nov. 9 it agreed to pay
$1.4 billion for exclusive live-broadcast rights for the UEFA
Champions League and the UEFA Europa League soccer games for
three years. BSkyB’s Sky Sports channels have aired top U.K.
soccer games since the Premier League’s inception in 1992.  RSA Insurance Group Plc (RSA)  plunged 11 percent to 108.1 pence,
its largest drop since Feb. 20. Britain’s biggest non-life
insurer by market value suspended three top executives at its
Irish unit and said 2013 results will miss  analysts’ estimates .  Cobham Plc tumbled 5 percent to 270.1 pence, its lowest
price since July 3. The world’s largest maker of airborne
refueling equipment said sales excluding acquisitions will
decline next year amid further cuts in U.S.  defense spending .  To contact the reporter on this story:
Inyoung Hwang in London at 
 ihwang7@bloomberg.net   To contact the editor responsible for this story:
Andrew Rummer at 
 arummer@bloomberg.net  